Quadrivalent influenza mRNA vaccine

influenza mRNA vaccine, quadrivalent · Sanofi Pasteur

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Quadrivalent influenza mRNA vaccine, covering 2025-06-19 to 2026-08-04. Get the full timeline:

Most recent: Clinical Trial Results: A Study to Investigate the Safety and Immunogenicity of the Quadrivalent Influenza mRNA Vaccines in Adults Aged 18 Years and Above [Phase 1, Phase 2]

See pricing